![Sally Thorne](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sally Thorne
Direktor/Vorstandsmitglied bei Michael Smith Foundation for Health Research
Ursprung des Netzwerks ersten Grades von Sally Thorne
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Michael Smith Foundation for Health Research
![]() Michael Smith Foundation for Health Research Investment Trusts/Mutual FundsMiscellaneous The Michael Smith Foundation for Health Research operates as a health research funding agency. The non-profit company is based in Vancouver, Canada. Diane Finegood has been the CEO of the Canadian company since 2012.
9
| Non-Profit Organization | Investment Trusts/Mutual Funds | 9 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Sally Thorne
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
University of British Columbia | College/University | Doctorate Degree Corporate Officer/Principal | |
The University of Nottingham | College/University | Undergraduate Degree | |
Canadian Institutes of Health Research
![]() Canadian Institutes of Health Research Miscellaneous Commercial ServicesCommercial Services The Canadian Institutes of Health Research is the federal health research financing organization in Canada. The non-profit company is based in Ottawa, Canada. The organization's main focus is to fund health research projects across the country. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
University of Toronto | College/University | Corporate Officer/Principal | |
REPLICEL LIFE SCIENCES INC. | Pharmaceuticals: Major | Director/Board Member | |
University of Western Ontario Hospital
![]() University of Western Ontario Hospital Other Consumer ServicesConsumer Services The University of Western Ontario Hospital is based in London, Canada. The hospital is affiliated with the University of Western Ontario and is a college/university hospital. | Other Consumer Services | Corporate Officer/Principal | |
University of Cambridge | College/University | Doctorate Degree | |
Institute of Human Development | Chief Tech/Sci/R&D Officer | ||
Andera Partners SCA
![]() Andera Partners SCA Investment ManagersFinance Andera Partners SCA (Andera Partners) is a private equity firm founded in 2001 by Pierre-Michel Passy. The firm is headquartered in Paris, France. | Investment Managers | Consultant / Advisor | |
Forbion Capital Partners Management Holding BV
![]() Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor | |
OXFORD BIOMEDICA PLC | Biotechnology | Director/Board Member | |
Prilenia Therapeutics BV
![]() Prilenia Therapeutics BV BiotechnologyHealth Technology Prilenia Therapeutics BV develops and manufactures pharmaceuticals. The company was founded in 2018 and is headquartered in Naarden, the Netherlands. | Biotechnology | Founder | |
Prilenia Therapeutics Development Ltd.
![]() Prilenia Therapeutics Development Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Prilenia Therapeutics BV, Prilenia Therapeutics Development Ltd. is a clinical stage biotech company based in Herzliya, Israel. Prilenia Therapeutics is developing its lead drug candidate, pridopidine, which is a sigma-1 receptor agonist and is in clinical development for the treatment of ALS and Huntington's disease. Pridopidine is currently part of the Healey ALS platform phase 2/3 clinical study and is in a phase 3 trial (PROOF-HD) with the Huntington Study Group, addressing functional capacity in early-stage HD patients. The pridopidine pipeline includes further indications in the pre-clinical phase. The Israeli company was founded by Michael R. Hayden in 2018 with the purpose of developing treatments for neurodegenerative and neurodevelopmental disorders. | Miscellaneous Commercial Services | Founder | |
Agency for Science, Technology & Research
![]() Agency for Science, Technology & Research Miscellaneous Commercial ServicesCommercial Services Agency for Science, Technology & Research engages in fostering scientific research and development. It is the agency for fostering world-class scientific research and talent for a vibrant knowledge-based and innovation-driven Singapore. The company was founded in 1991 and is headquartered in Singapore. | Miscellaneous Commercial Services | Director/Board Member | |
GlobaR&D Co. ,Ltd | President | ||
Lawson Research Institute | Chief Tech/Sci/R&D Officer | ||
Child & Youth Health | Chief Tech/Sci/R&D Officer | ||
KINTARA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
University of Ottawa | College/University | Undergraduate Degree | |
University of Western Ontario | College/University | Graduate Degree | |
Provincial Health Services Authority
![]() Provincial Health Services Authority Medical/Nursing ServicesHealth Services Provincial Health Services Authority operates as a health authority system which provides healthcare services. The firm provides transplantation, emergency health services, cardiac services and perinatal services. The company was founded on December 12, 2001 and is headquartered in Vancouver, Canada. | Medical/Nursing Services | Chief Executive Officer | |
Canadian Blood Services
![]() Canadian Blood Services Internet Software/ServicesTechnology Services Canadian Blood Services is a company that provides plasma protein and related products to hospitals across Canada (except Quebec). Canadian Blood Services relies on the generosity of donors to help many patients in need. The non-profit company is based in Ottawa, Canada. The company is committed to standing in solidarity with 2SLGBTQIA+ communities as pride celebrations begin across the country. The company emphasizes the importance of knowing one's blood type, as it determines who can donate blood and who can receive it. | Internet Software/Services | Chief Executive Officer | |
BC Women's Hospital & Health Centre Foundation | Chief Executive Officer | ||
Comprehensive Care International
![]() Comprehensive Care International Miscellaneous Commercial ServicesCommercial Services Comprehensive Care International engages in healthcare services. It specializes in clinical programs, multidisciplinary facilities, and community health networks. Its offer healthcare fields include oncology, healthcare facilities development, and healthcare management. The firm offers support, assessment, implementation, design, and planning. The company is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
British Columbia Rapid Transit Co. Ltd.
![]() British Columbia Rapid Transit Co. Ltd. Other TransportationTransportation British Columbia Rapid Transit Co. Ltd. provides passenger rail transportation service and is ultimately controlled by the South Coast British Columbia Transportation Authority. The company is based in Burnaby, Canada. | Other Transportation | Chairman | |
Sunny Hill Health Centre for Children | Chief Executive Officer | ||
Canadian Association of Gastroenterology
![]() Canadian Association of Gastroenterology Miscellaneous Commercial ServicesCommercial Services Canadian Association of Gastroenterology promotes the study of the digestive tract in health and disease. It supports the development and maintenance of formal educational research component within Gastroenterology in Canada. The company was founded in 1962 and is headquartered in Oakville, Canada. | Miscellaneous Commercial Services | Chairman | |
Conseil canadien pour la diversité administrative
![]() Conseil canadien pour la diversité administrative Financial ConglomeratesFinance Conseil canadien pour la diversité administrative is a private company based in Toronto, Canada. The Canadian company provides funds for startup companies. | Financial Conglomerates | Corporate Officer/Principal | |
University of Calgary | College/University | Corporate Officer/Principal | |
University of Manitoba | College/University | Doctorate Degree | |
ABCELLERA BIOLOGICS INC. | Biotechnology | Director/Board Member | |
89BIO, INC. | Pharmaceuticals: Major | Founder | |
National University of Singapore | College/University | Corporate Officer/Principal | |
Summatix Pty Ltd.
![]() Summatix Pty Ltd. Internet Software/ServicesTechnology Services Summatix Pty Ltd. operates as a medical data monetization platform. The firm provides connectivity to its HIPAA compliant platform, software, APIs, and data management. The company is headquartered in Melbourne, Australia. | Internet Software/Services | Director/Board Member | |
McGill University | College/University | Undergraduate Degree | |
CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Chief Executive Officer | |
Premier's Technology Council | General Government | Corporate Officer/Principal | |
Richardson Capital Ltd.
![]() Richardson Capital Ltd. Investment ManagersFinance Richardson Capital Ltd. (Richardson Capital) is a private equity arm of Richardson Financial Group Ltd founded in 2003. The firm is headquartered in Winnipeg, Canada. | Investment Managers | Corporate Officer/Principal | |
Angiotech Pharmaceuticals, Inc.
![]() Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Medical Specialties | Chief Executive Officer | |
REX BIONICS PLC | Medical Specialties | Director/Board Member | |
EPIRUS BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Active Pass Pharmaceuticals, Inc.
![]() Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Active Pass Pharmaceuticals, Inc. develops drugs for infectious diseases. It engages in the development of drugs that inhibit ABC transporters. The firm also provides portfolio of therapeutic programs, including age-related macular degeneration, travelers' diarrhea, and lipid disorders. The company was founded by Peter B Reiner in 1998 and is headquartered in Vancouver, Canada. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
Kanada | 31 |
Vereinigtes Königreich | 7 |
Vereinigte Staaten | 6 |
Singapur | 3 |
Australien | 3 |
Sektoral
Health Technology | 17 |
Consumer Services | 12 |
Finance | 7 |
Commercial Services | 6 |
Technology Services | 3 |
Operativ
Director/Board Member | 40 |
Corporate Officer/Principal | 13 |
Independent Dir/Board Member | 12 |
Chief Executive Officer | 10 |
Founder | 9 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Michael Hayden | 27 |
Bill Hunter | 22 |
Lynda Cranston | 12 |
John R. G. Challis | 11 |
Thomas Feasby | 5 |
Michael Hayden | 1 |
Nancy Mathias | 1 |
Lori Last | 1 |
Diane Finegood | 1 |
- Börse
- Insiders
- Sally Thorne
- Unternehmensverbindungen